ENTBF ENTHEON BIOMEDICAL CORP
- 0.115900
- -0.028460-19.71%
ENTHEON BIOMEDICAL CORP News
ENTHEON BIOMEDICAL CORP To Carry Out 1-for-10 Reverse Stock Split On March 1st, 2024
February 29th - $ENTHEON BIOMEDICAL CORP(ENTBF.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from March 1st, 2024.$ENTHEO
RBC Downgrades Nevro to Sector Perform, Cites Salesforce Turnaround
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders
FinancialNewsMedia.com News Commentary PALM BEACH, Fla., July 27, 2022 /PRNewswire/ -- For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vie
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider. Numinus (OTC:NUMIF) concluded its acquisition of Novamind (OTC
Cybin to acquire DMT clinical study from Entheon Biomedical
Cybin (NYSE:CYBN) added ~8% in the pre-market Tuesday after the psychedelics-focused biopharma announced that its subsidiary Cybin IRL Limited agreed to acquire a Phase 1 N,N-dimethyltryptamine ("DMT"
Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research
Ehave, Inc. (OTC:EHVVF) is a leading healthcare services and technology company focused on progressing psychedelics to therapeutics by engineering novel compounds and new treatment protocols for treat
Entheon Biomedical Announces Non-Brokered Private Placement Financing
Entheon Biomedical Corp. (OTCQB:ENTBF) announced a non-brokered private placement financing for up to 30,000,000 Units at a price of CDN$0.10 per unit, for gross proceeds of up to CDN$3,000,000. Each
Entheon Biomedical begins enrollment in phase 1 study of DMT for addiction disorders
Entheon Biomedical (OTCQB:ENTBF) said the first patient was enrolled in a phase 1 trial called EBRX-101 evaluating N, N-dimethyltryptamine (DMT) for addiction disorders. In the study — which is being
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,
Entheon Biomedical Acquires Lobo Genetics, Inc. in Bid to Strengthen Screening and Treatment Evaluation Tech for Psychedelics
Image Provided by Wiki Commons Entheon Biomedical Corp. (OTCQB:ENTBF), the biotech research and development company focused on developing DMT-based treatments for addiction and substance use disorders
The number of first-time jobless claims in the United States rose last week and the number of people in Louisiana soared
The number of people applying for unemployment benefits for the first time in the United States increased last week, and the number of people in Louisiana soared under the influence of Hurricane Ida. The number of first-time jobless claims rose to 332000 in the week ended Sept. 11, according to data released by the Labor Department on Thursday. Economists surveyed by Bloomberg expected a median of 322000. In the week ended September 4, the number of continuing jobless claims fell to 2.7 million. The rise in first-time jobless claims may reflect fluctuations in weekly data at a time when the labour market is fully recovering and demand for labour is increasing. However, in view of the reduction in stimulus spending, third,
"terrorist data" US retail sales unexpectedly improved in August, with spot gold prices falling $5 in the short term to continue their intraday decline.
The original title: "terrorist data" US retail sales unexpectedly improved in August. Spot gold prices fell by $5 in the short term to continue their intraday decline at 20:30 Beijing time on Thursday. The United States released the market-focused terrorist data on US retail sales in August. As a result, the data unexpectedly improved, exceeding expectations and recording a positive value. After the release of the data, the spot gold price fell slightly by $5 in the short term, extending the intraday decline. Figure: spot gold price 5 minutes chart specific data show that the monthly rate of retail sales in the United States in August actually announced 0.70%, expected to be-0.7%, the previous value is-1.1%; retail sales in the United States in August
Singapore's richest man replaced: Li Xiaodong, CEO of Donghai Group, is worth 19.8 billion US dollars.
Li Xiaodong, co-founder, chairman and CEO of Singapore's Sea Ltd., the largest Internet company in Southeast Asia, has become the new richest man in the city-state, worth $19.8 billion. Donghai's American depositary receipts (ADR) have risen 67 per cent so far this year, pushing Li Xiaodong's worth soar, surpassing paint magnate Goh Cheng Liang, who now has a net worth of $17.7 billion. This is another example of tech millionaires rising in the wealth rankings of Asian countries. Earlier this year, South Korean communications giant Kakao Corp.
Psyched: Atai Life Sciences Hits Nasdaq, Canada To Fund Ketamine Trials, Mydecine Launches AI Drug-Discovery Platform
Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq debut on Friday. The Berlin-based company is joining an exclusive group of start-ups in the psychedelics sector to IPO this year o
Analysis
Price Target
No Data
